JANICE BIRKHOFF: Open Payments
NPI 1952580839 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,768 in 174 payments from 17 companies in 2025. Trend: 2023 $1,134 · 2024 $2,221 · 2025 $2,768
Food & beverage: $2,602Education: $166
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 34 | $583 |
| UCB, Inc. | 26 | $426 |
| ABBVIE INC. | 40 | $319 |
| Janssen Biotech, Inc. | 10 | $302 |
| Galderma Laboratories, L.P. | 19 | $276 |
| GENZYME CORPORATION | 11 | $199 |
| Amgen Inc. | 13 | $185 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| PFIZER INC. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
Products named: Bimzelx, ADBRY, DUPIXENT, TREMFYA, NEMLUVIO, ANZUPGO, SKYRIZI, OTEZLA.
Industry payments across LA — which companies pay providers there.
